Concepedia

Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

Joan Albanell, Antonio González, Manuel Ruíz‐Borrego, Emilio Alba, José Á. García-Sáenz, J. Corominas, Octavio Burgués, Vicente Furió, A. Rojo, José Palacios,

Annals of Oncology · 2011 · 120 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Gene expression profiling predicts clinical outcome of breast cancer

Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver et al. · Nature · 2002 · 9.6K citations · Full text

, , +16

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Soonmyung Paik, Steven Shak, Gong Tang et al. · New England Journal of Medicine · 2004 · 6.4K citations · Full text

, , +12

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations · Full text

, , +11

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett et al. · Journal of Clinical Oncology · 2010 · 4.3K citations · Full text

, , +14

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Stefan Aebi, T. Davidson, Günther Gruber et al. · Annals of Oncology · 2010 · 2.9K citations · Full text

, , +14